Recurrent leg ulcers and arterial thrombosis in a 33-year-old homozygous variant of antithrombin

American Journal of Hematology

Volumn 66, Issue 4, 2001, Pages 285-291

  Shimizu, Kazuhiro ^a,b   Toriyama, Fumi ^a   Ogawa, Fumihide ^b   Katayama, Ichiro ^c   Okajima, Kenji ^a  

^a National Hospital Organization   (Japan)

^b NAGASAKI UNIVERSITY   (Japan)

^c KUMAMOTO UNIVERSITY   (Japan)

Author keywords

Arterial thrombosis; Congenital antithrombin deficiency; Homozygous variant; Leg ulcer

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; HEPARIN COFACTOR;

ADULT; AFFINITY CHROMATOGRAPHY; ANTITHROMBIN DEFICIENCY; ARTERY THROMBOSIS; ARTICLE; CASE REPORT; CROSSED IMMUNOELECTROPHORESIS; DEEP VEIN THROMBOSIS; GENE MUTATION; HOMOZYGOSITY; HUMAN; LEG ULCER; LIPODERMATOSCLEROSIS; NUCLEOTIDE SEQUENCE; PEDIGREE; PHLEBOGRAPHY; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RECURRENT DISEASE; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SEQUENCE ANALYSIS; VEIN INSUFFICIENCY;

ADULT; AMINO ACID SUBSTITUTION; ANTICOAGULANTS; ANTITHROMBIN III; ANTITHROMBIN III DEFICIENCY; ARTERIAL OCCLUSIVE DISEASES; CEREBRAL INFARCTION; CONSANGUINITY; COOKERY; EDEMA; ENDOTHELIUM, VASCULAR; EPOPROSTENOL; EXONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HEPARIN; HOMOZYGOTE; HUMANS; LEG ULCER; MALE; MUTATION, MISSENSE; OCCUPATIONAL DISEASES; PEDIGREE; POSTURE; PROTEIN BINDING; RECURRENCE; THROMBOPHILIA; THROMBOPHLEBITIS; THROMBOSIS;

EID: 0035093754     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajh.1059     Document Type: Article

References (21)

1. Disease of the veins and arteries. Leg ulcers
2. Antithrombin mutation database: 2nd (1977) update
3. Different prevalence of thromboembolism in the subtypes of congenital antithrombin III deficiency: Reviews of 404 cases
4. Homozygous antithrombin deficiency: Report of two new cases (99 Leu to Phe) associated with arterial and venous thrombosis
5. Antithrombin III Nagasaki (Ser116-Pro): A heterozygous variant with defective heparin binding associated with thrombosis
6. Homozygous variant of antithrombin III that lacks affinity for heparin: AT III Kumamoto
7. Antigen-antibody crossed electrophoresis
8. A cunctional assay for protein C in human plasma
9. Determination of plasma protein S. The protein cofactor of activated protein C efficiency
10. Plasma and serum antithrombin III: Differentiation by crossed immunoelectrophoresis
11. Analysis of human Y-chromosome-specific reiterated DNA in chromosome variants
12. Primer-directed enzymatic amplification of DNA with a themostable DNA polymerase
13. Activated protein C resistance and anticardiolipin antibodies in patients with venous leg ulcers
14. Mutation in blood coagulation factor V associated with resistance to activated protein C
15. Rapid simultaneous screening for Factor V Leiden and G20210A prothrombin variant by multiplex polymerase chain reaction on whole blood
16. Leg ulcers
17. 506 Q mutation in the gene for factor V is a common risk factor for venous thrombosis
18. Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells
19. The anti-inflammatory properties of antithrombin III: New therapeutic implications
20. Effects of prostacycliln on cyclic AMP concentration in human platelets
21. Cardiovascular actions of prostacyclin in chloralose anesthetized dogs